Search results for "From ACP Internist Weekly"


 
Results 1 - 10 of about 49 for "From ACP Internist Weekly".
Sort by: Relevance | Newest | Oldest

Apixaban associated with lower risk of GI bleeding compared to other DOACs

Apixaban users experienced similar rates of ischemic stroke or systemic embolism, intracranial hemorrhage, and all-cause mortality as patients taking other direct oral anticoagulants (DOACs), a retrospective analysis found.
https://gastroenterology.acponline.org/archives/2022/11/18/6.htm
18 Nov 2022

Guideline suggests prescription medications when lifestyle change ineffective for weight loss

For adults with obesity or overweight with weight-related complications, the American Gastroenterological Association found moderate certainty of benefit for four medications: semaglutide, liraglutide, phentermine-topiramate ER, or naltrexone-bupropion.
https://gastroenterology.acponline.org/archives/2022/10/28/6.htm
28 Oct 2022

Continuing anti-TNF therapy in pregnancy appears beneficial for patients with IBD

A French target trial emulation, which refers to the use of observational data to mimic a randomized controlled trial, found that maternal relapse of inflammatory bowel disease (IBD) and premature births were less common when patients continued anti-tumor necrosis factor (anti-TNF) therapy after 24 weeks of pregnancy than when the drugs were discontinued.
https://gastroenterology.acponline.org/archives/2022/10/28/8.htm
28 Oct 2022

European trial finds reduction in cancers but not deaths with invitation to colonoscopy screening

Healthy patients in Poland, Norway, and Sweden were randomized to usual care or an invitation to screening colonoscopy; only 42% of invited patients responded. The invited group had an 18% lower risk of colorectal cancer at 10 years compared to the usual care group.
https://gastroenterology.acponline.org/archives/2022/10/28/7.htm
28 Oct 2022

6-food elimination diet may work for more than half of patients with eosinophilic esophagitis

Removing milk, wheat, soy, eggs, tree nuts/peanuts, and fish/shellfish from one's diet and then gradually reintroducing these food categories identified a single food trigger for 69% of participating patients with eosinophilic esophagitis, a retrospective study found.
https://gastroenterology.acponline.org/archives/2022/08/26/7.htm
26 Aug 2022

Hepatitis B vaccine now recommended for adults ages 19 through 59 years

The Advisory Committee on Immunization Practices has changed its guidance to encourage clinicians to offer the vaccine to adult patients, rather than target those with risk factors or wait for it to be requested.
https://gastroenterology.acponline.org/archives/2022/04/22/6.htm
22 Apr 2022

Flexible sigmoidoscopy associated with long-term reduction in colorectal cancer incidence, mortality

Colorectal cancer incidence and mortality were reduced by about 20% in patients who were randomized to receive once-only flexible sigmoidoscopy screening between the ages of 55 to 64 years instead of usual care.
https://gastroenterology.acponline.org/archives/2021/11/19/6.htm
19 Nov 2021

AGA clinical practice update offers guidance on PPI deprescribing

All patients taking a proton-pump inhibitor (PPI) should have a regular review and documentation of ongoing indications for use, which should be the responsibility of the primary care clinician, the American Gastroenterological Association (AGA) said.
https://gastroenterology.acponline.org/archives/2022/02/25/6.htm
25 Feb 2022

Apixaban shows superior effectiveness, safety compared to rivaroxaban

For patients with venous thromboembolism, initiation of apixaban was associated with lower rates of recurrence and intracranial and gastrointestinal bleeding than rivaroxaban in a population-based cohort study.
https://gastroenterology.acponline.org/archives/2021/12/17/6.htm
17 Dec 2021

Phentermine-topiramate most effective drug for weight loss, meta-analysis finds

Among glucagon-like peptide-1 receptor agonists, semaglutide appeared to be the most effective for weight loss, with a higher likelihood of weight loss of 5% or more and percentage body weight change and a similar risk of adverse events.
https://gastroenterology.acponline.org/archives/2021/12/17/7.htm
17 Dec 2021

Result Page: Prev   1   2   3   4   5   Next